Nearly 3 million ST-segment elevation myocardial infarction ( STEMI) are predicted to occur in India per year. Clopidogrel reloading is most frequently used in STEMI patients who are already taking clopidogrel, particularly for STEMI. The current article describes a recent study which reported that Clopidogrel reloading is safe in most patients with MI .
A recent study published in the European heart journal determined the association between clopidogrel reloading with in-hospital bleeding and mortality in existing practice. Study design: The study analyzed clopidogrel reloading indicated for STEMI and non-ST-segment elevation myocardial infarction (NSTEMI) patients who were on preexisting clopidogrel therapy from 2009 to 2014. The researchers used inverse probability weighted propensity adjustment to compare in-patient mortality and major risks of bleeding among patients reloaded in…
